Betalin Therapeutics
Betalin Therapeutics is a Healthcare & Life Sciences startup based in Israel, most recent round Series A, 2 tracked investors.
About Betalin Therapeutics
Betalin Therapeutics is a company founded in 2015 headquartered in Israel. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Betalin Therapeutics is an Israeli biotech company developing an implantable micro‑pancreas that uses transplanted insulin-producing cells and stem-cell technologies to sense blood glucose and release regulated insulin, aiming to reduce or eliminate patients' dependence on injected insulin for diabetes management.
Explore Betalin Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.